Revvity Income from Discontinued Operations 2010-2025 | RVTY
Revvity annual/quarterly income from discontinued operations history and growth rate from 2010 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
- Revvity income from discontinued operations for the quarter ending March 31, 2025 was $0.001B, a 121.17% decline year-over-year.
- Revvity income from discontinued operations for the twelve months ending March 31, 2025 was $-0.009B, a 72.02% decline year-over-year.
- Revvity annual income from discontinued operations for 2024 was $-0.013B, a 102.47% decline from 2023.
- Revvity annual income from discontinued operations for 2023 was $0.514B, a 808.96% increase from 2022.
- Revvity annual income from discontinued operations for 2022 was $0.057B, a 5.18% increase from 2021.
| Revvity Annual Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2024 | $-13 |
| 2023 | $514 |
| 2022 | $57 |
| 2021 | $54 |
| 2020 | $97 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $136 |
| 2016 | $19 |
| 2015 | $24 |
| 2014 | $28 |
| 2013 | $-7 |
| 2012 | $-1 |
| 2011 | $6 |
| 2010 | $252 |
| 2009 | $9 |
| Revvity Quarterly Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1 |
| 2024-12-31 | $6 |
| 2024-09-30 | $1 |
| 2024-06-30 | $-17 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $15 |
| 2023-09-30 | $-23 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $545 |
| 2022-12-31 | $30 |
| 2022-09-30 | $16 |
| 2022-06-30 | $18 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $34 |
| 2021-09-30 | $20 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $97 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $1 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $0 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $141 |
| 2017-03-31 | $3 |
| 2016-12-31 | $3 |
| 2016-09-30 | $4 |
| 2016-06-30 | $6 |
| 2016-03-31 | $6 |
| 2015-12-31 | $24 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $31 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-7 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $0 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $1 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $9 |
| 2011-06-30 | $1 |
| 2011-03-31 | $-2 |
| 2010-12-31 | $250 |
| 2010-09-30 | $-13 |
| 2010-06-30 | $10 |
| 2010-03-31 | $5 |
| 2009-12-31 | $14 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-2 |
| 2009-03-31 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.196B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.61 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.62 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| OncoCyte (IMDX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |